TARS SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0001274173-26-000207
TARS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 13, 2026. An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Tarsus Pharmaceuticals (TARS). The stock moved -1.6% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Tarsus Pharmaceuticals (TARS). The filing indicates a passive investment stake with no reported change in control intent.
Key details
How TARS stock reacted
Close before
$70.02
Aug 12, 2026
First close after
-1.62%
$68.88
5 trading days
+4.89%
$73.44
Since filing
-2.02%
$68.60
✦ Ask GOAX AI about this filing — what it means for TARS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TARS?
Click hereFrequently asked questions
What did TARS file with the SEC on Aug 13, 2026?
TARS filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Tarsus Pharmaceuticals (TARS). The filing indicates a passive investment stake with no reported change in control intent.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did TARS stock react to this filing?
TARS closed at $70.02 before the filing and $68.88 on Aug 13, 2026 (-1.62%). Five trading days later: $73.44 (+4.89%).
Other TARS SEC filings
Get alerts when TARS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days